amplimed.com
AmpliMed Home, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicitiesNo description found
http://www.amplimed.com/
No description found
http://www.amplimed.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
2.9 seconds
Kliuchenia Yauheni
Tukhach●●●●●●● street
Mi●●sk , The Minsk area, 220026
Belarus
View this contact
Kliuchenia Yauheni
Tukhach●●●●●●● street
Mi●●sk , The Minsk area, 220026
Belarus
View this contact
Kliuchenia Yauheni
Tukhach●●●●●●● street
Mi●●sk , The Minsk area, 220026
Belarus
View this contact
BUY YOUR DOMAIN
20
YEARS
11
MONTHS
8
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
6
SITE IP
89.111.176.186
LOAD TIME
2.888 sec
SCORE
6.2
AmpliMed Home, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities | amplimed.com Reviews
https://amplimed.com
<i>No description found</i>
amplimed.com
AmpliMed Management, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
http://www.amplimed.com/principals.html
Dr Robert T. Dorr – President and Chief Executive Officer. Dr Evan Hersh – Executive VP and Chief Medical Officer. Chris Richied – VP and Chief Financial Officer. Dr William A. Remers – VP, Chemistry and Manufacturing. Steve Steinman –. VP, Regulatory and Quality Assurance. Kathryn Grenier – VP, Clinical Operations. Robert T. Dorr. Evan M. Hersh. Christopher R. Richied. William A. Remers.
AmpliMed Physicians, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
http://www.amplimed.com/physicians.html
About Amplimexon (imexon, inj.). Amplimexon , an anticancer drug with a novel mechanism of action, is minimally myelosuppressive, and only at the highest doses. It also overcomes multi-drug resistance. AmpliMed is currently conducting a randomized phase II clinical trial in which Amplimexon is being administered in combination with gemcitabine (Gemzar ) in metastatic pancreatic cancer. Additional studies being planned include malignant melanoma and lung cancer.
AmpliMed Investors, Amplimed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
http://www.amplimed.com/investors.html
Since 2004, AmpliMed has raised a total of $33.1 million which has been used to conduct eight clinical trials involving over 400 cancer patients:. 2009 Series D for $3.8 million. 2007 Series C for $5.1 million. 2006 Series B for $14.6 million. 2004 Series A for $9.6 million. Our current investors include:. Valley Ventures III LP (Scottsdale/Tucson). Axion Capital Management, LLC. Biotech Insight Management, LLC) (San Rafael, CA). Village Ventures (Denver, CO).
AmpliMed EntryPoint, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
http://www.amplimed.com/media.html
Welcome. We've developed the following information to provide the essentials about AmpliMed Corporation. Amplimexon has completed Phase I and II clinical trials, and is currently being used in a Phase II trial in pancreatic cancer (AMP-019). Future studies are planned in non-small cell lung cancer (NSCLC) and malignant melanoma. The Company has several other series of drugs under preclinical development, including a series of cyanoaziridine compounds (analog of Amplimexon ). And bibliographies of research.
AmpliMed Patients and Trials, Amplimed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
http://www.amplimed.com/patients.html
AmpliMed Corporation is currently planning and/or recruiting patients for clinical studies in a number of areas. To learn more about the upcoming studies, click on the indication below. Protocol AMP-019: Pancreatic Cancer. Protocol AMP-024: Non Small Cell Lung Cancer. Protocol AMP-008: Malignant Melanoma. For additional information about AmpliMed Corporation and the clinical trials, please have your physician contact one of the centers listed under the indications noted above. Evan M. Hersh, M.D.
TOTAL PAGES IN THIS WEBSITE
9
Finney Capital: Portfolio
http://finney.biz/biz/portfolio.html
MJ Research, Inc. (Including MJ Bioworks and MJ Geneworks) 1986 - 2004; board seat 1986-2004. Developed, manufactured, and sold instruments and reagents for use in life science research. At the time it was acquired by Bio-Rad Laboratories in 2004, it was privately held and had annualized sales of approximately $90 million. 1996 - 2008; board seat 1996-2008. Import, manufacture, and sale of biotechnology products in Australia and New Zealand. Exit: Management buyout. Orion Genomics, LLC. Sage Science, Inc.
Finney Capital: Portfolio
http://www.finneycapital.com/portfolio.html
MJ Research, Inc. (Including MJ Bioworks and MJ Geneworks) 1986 - 2004; board seat 1986-2004. Developed, manufactured, and sold instruments and reagents for use in life science research. At the time it was acquired by Bio-Rad Laboratories in 2004, it was privately held and had annualized sales of approximately $90 million. 1996 - 2008; board seat 1996-2008. Import, manufacture, and sale of biotechnology products in Australia and New Zealand. Exit: Management buyout. Orion Genomics, LLC. Sage Science, Inc.
AmpliMed Corp.: Series C $22.0M | OnBioVC
https://onbiovc.wordpress.com/2008/01/20/amplimed-corp-series-c-220m
From the A to the Exit: What is Happening in Bio VC. AmpliMed Corp.: Series C $22.0M. Tucson, AZ) a clinical-stage pharmaceutical company with Phase II lead compounds for malignant melanoma and pancreatic cancer closed on $5M traunche of a $22M Series C financing. Participants include BioMed Venture Partners, Biotech Insight Ventures, Solstice Capital and Valley Ventures. This entry was posted on Sunday, January 20th, 2008 at 1:04 am and is filed under I - Series C. R - SOUTH WEST. From your own site.
Arizona's BioTech News Update: October 2005
http://azbiotech.blogspot.com/2005_10_01_archive.html
Arizona's BioTech News Update. Moved to www.azbiotechnews.com. Monday, October 31, 2005. Flagstaff is the hub of Gore's medical-products division, the site of development and manufacturing of implantable medical devices.). Posted by AZ Biotech at 10:44 PM. Links to this post. Computational systems biology comes to a lab bench near you. Posted by AZ Biotech at 8:43 AM. Links to this post. Anti-flu vaccine race gets new entry. The nascent technology, called DNA vaccines, is a form of gene therapy that prop...
TOTAL LINKS TO THIS WEBSITE
6
amplimatic.com
Amplimatic.com may be available for further development. Enter your search terms.
Home - Amplimed Synchro - die sanfte Elektrotherapie für Tiere
Mittelfrequenz Elektrotherapie - Speziell für die Tiermedizin. Aus Amplimed Synchro wird. Mittelfrequenztherapie in der Veterinärmedizin. Herzlich Willkommen auf unseren Informationsseiten zum Thema Amplimed und seinem Nachfolger Amplimove animal. Gerne beraten wir Sie auch persönlich - eine kurze email an info@amplimed-synchro.de. Mit Angabe Ihrer Rufnummer für einen Rückruf beantworten wir innerhalb 24 Stunden. Hier kann man das Amplimove erwerben. C) PET PHYSIO eK.
AmpliMed synchro - AmpliMed synchro
Ist ein Mittelfrequenz Elektrotherapie Gerät (MET). Das AmpliMed synchro arbeitet mit einer Grundfrequenz von 2.000 Hz bzw. 6.000 Hz, die in der Amplitude moduliert wird. Es werden drei therapeutisch wirksame Frequenzen genutzt:. Mittelfrequenz (Grundfrequenz von 2kHz oder 6kHz). Niederfrequenz (Amplitudenmodulation von 5Hz bis 100Hz). Schwellfrequenz (Amplitudenmodulation von 1 bis 100 Imp./min.). Man spricht auch von der Modulations-Elektro-Therapie oder amplituden modulierte Mittelfrequenztherapie.
AmpliMed Home, AmpliMed is a cancer research chemotherapy corporation with a drug class that features novel mechanisms of action that can defeat MDR and some toxicities
Amplimed Audifonos
Centro Audiológico: Tte. Gral. Juan D. Perón 1873 6º A CABA. Es un Centro Audiológico formado por un equipo de profesionales de la audición, organizados para la atención del paciente hipoacúsico de manera integral. Somos importadores directos de las reconocidas marcas internacionales y distribuimos nuestros productos en todo el país. 2014 Amplimed Audiología - info@amplimed.com.ar. Diseño: Next Publicitario.
Amplimed: Software médico para clínicas e consultórios
O melhor sistema médico online para gestão de clínicas e consultórios. Assista nosso vídeo abaixo e conheça mais. Inicie agora um teste grátis. De 15 dias e se surpreenda! Nós não compartilhamos suas informações pessoais com ninguém. Porque escolher o Amplimed. Sistema médico online completo que se encaixa. Perfeitamente em sua clínica. Nosso sistema médico online conta com um apoio de especialistas médicos para aperfeiçoamento constante do produto. Conheça mais o nosso produto. Agenda dinâmica e persona...
AmpliMed-MET
AmpliSystems- MET : : : : : : :. Das steht für fast 2 Jahrzehnte Kompetenz durch Forschung und Erfahrung aus der Praxis für die Praxis. Generation der "original MET-Systeme nach Knop". Ist in der Veterinär-Version (Ampli Vet. Incl der 15 neuen TheraKarts ab sofort lieferbar. Der Generalvertrieb liegt exklusiv nur noch bei Susanne Arens und ihren Partnern - www.amplivet.eu. Der nächste Anwender-WorkShop mit der Initiatorin TPT Susanne Arens am 08.12. Wir bitten um Ihr Verständnis! Timer 5 bis 60 min.
Home Security Screens & Insect Screens - Amplimesh - NZ
SupaScreen Security Doors and Windows. Security Grilles; Doors and Windows. What To Look For. What to look for in a Genuine Security Door. Warranty Terms and Conditions. Warranty Terms and Conditions. Range of quality security doors and fly screen innovations have been protecting New Zealand homes for over 40 years.". BECOME AN AMPLIMESH DEALER. The ultimate in uncompromising total barrier protection. Modern security screens for your home. Breakthrough protection for your family and home.
Security Doors & Windows, Security Screen & Safety Doors
Protecting families for over 50 years. Combining looks and practicality, improving the. Liveability of homes, Amplimesh Security Screens. Are icons in the Australian security market. It's easy to see why, over the last fifty years, more than two million Australians have trusted Amplimesh to secure their homes. Amplimesh security doors and window screens are clearly Australia’s first choice in keeping homes safe and secure. The best security,. Never looked so good! Combining looks and practicality,. Chanc...
